Sign In  |  Register  |  About Pleasanton  |  Contact Us

Pleasanton, CA
September 01, 2020 1:32pm
7-Day Forecast | Traffic

  • Search Hotels in Pleasanton

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Vertex Pharmaceuticals (NQ: VRTX )

450.37 -0.86 (-0.19%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,503,359
Open 454.24
Bid (Size) 450.35 (2)
Ask (Size) 452.50 (3)
Prev. Close 451.23
Today's Range 445.00 - 455.43
52wk Range 346.29 - 519.88
Shares Outstanding 259,428,394
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
A Closer Look at Vertex Pharmaceuticals's Options Market Dynamics
Via Benzinga
3 Growth Stocks You Can Buy Right Now Without Any Hesitation
Via The Motley Fool

Performance

YTD
+9.60%
+9.60%
1 Month
-5.80%
-5.80%
3 Month
-7.35%
-7.35%
6 Month
+0.63%
+0.63%
1 Year
+26.94%
+26.94%

More News

Read More
2 Top Biotech Stocks to Buy Now and Hold For 5 Years or More
Via The Motley Fool
Prediction: This Biotech Stock Is Heading for a Once-in-a-Generation Opportunity
Via The Motley Fool
Biotech Stocks Are Rallying: What Is Your Playbook?
Via Talk Markets
Five S&P 500 Stocks, All Elite IBD Giants, Near Buy Points
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
Spotlight on Vertex Pharmaceuticals: Analyzing the Surge in Options Activity
Via Benzinga
Assessing Vertex Pharmaceuticals: Insights From 11 Financial Analysts
Via Benzinga
Stock Market Surges To Highs On Trump Election; Fed Cuts Rates, Palantir Soars: Weekly Review
Via Investor's Business Daily
Topics Economy Government
Exposures Interest Rates Political
2 Biotech Stocks You Can Buy Hand Over Fist This Month
Via The Motley Fool
Wall Street Rallies On Election Day, Palantir Skyrockets, Bitcoin Tops $70,000: What's Driving Markets Tuesday?
Via Benzinga
5 Top Stocks to Buy in November
Via The Motley Fool
My 2 Favorite Growth Stocks to Buy Hand Over Fist in November
Via The Motley Fool
Vertex Pharmaceuticals (VRTX) Q3 2024 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
Vertex Pharmaceuticals Beats Third-Quarter Estimates As Pain Treatment Looms
Via Investor's Business Daily
Vertex Reports Third Quarter 2024 Financial Results
From Vertex Pharmaceuticals Incorporated
Via Business Wire
Volatility Hits Large Cap Biopharma: Active Rebalancing May Be Required
Via Talk Markets
Wall Street Struggles Ahead Of Election Day, Energy Sector Outperforms, Solar Stocks Rise: What's Driving Markets Monday?
Via Benzinga
Jim Cramer Says Vertex Doing 'Lord's Work': Can Q3 Earnings Outshine Bearish Charts?
Via Benzinga
Thinking of Buying CRISPR Therapeutics Stock? Watch These 2 Key Numbers
Via The Motley Fool
As Stock Market Awaits Election, Palantir, S&P 500 Nuke Leaders Report
Via Investor's Business Daily
Topics Economy Stocks
Exposures Interest Rates US Equities
Jim Cramer: This Financial Stock Is 'One Of The Most Consistent, Great Companies'
Via Benzinga
Vertex to Participate in Upcoming November Investor Conferences
From Vertex Pharmaceuticals Incorporated
Via Business Wire
Here's How Much You Would Have Made Owning Vertex Pharmaceuticals Stock In The Last 5 Years
Via Benzinga
These 10 Stocks Were The Best S&P 500 Performers In 2017 When Trump Was President: Will History Repeat Itself?
Via Benzinga
Topics Government Stocks
Exposures Political US Equities
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photography by Christophe Tomatis
Copyright © 2010-2020 Pleasanton.com & California Media Partners, LLC. All rights reserved.